HMGB1 is utilized by tumor cells to divert the potentially protective activities of the innate immune system, specifically those involving activation of TLR4, as well as RAGE, to generate a hyperinflammatory, immunosuppressive, protumorigenic TME. This evidence concerns the gene HMGB1 and neoplasm.